?

?

World Vaccine Congress Washington 2019

?

R & D?+?Strategic Partnering For The Global Vaccine Industry

?

World's Most Exciting Vaccine Event

?

? April 06, 2020?- Pre- Congress Workshops

?April 07-09, 2020?- Main Congress

Walter E. Washington Convention Center

?

?

THOUSANDS

Attendees
500+
Companies

HUNDREDS

Speakers
100+
Exhibitors
10
Conferences
8
Workshops

Scientific Advisory Board

?

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Gregory A. Poland

Director of Mayo Vaccine Research Group

Mayo Clinic

Bali Pulendran, Dpt of Pathology, Microbiology & Immunology, Stanford University School of Medicine

Prof Bali Pulendran

Department of Pathology, Microbiology & Immunology

Stanford Universty School of Medicine

?

Dr Bruce Gellin, President of Global Immunization, Sabin Institute

Dr Bruce Gellin

President of Global Immunization

Sabin Institute

Dr Heidi Larson, Professor of Anthropology, Risk and Decision Science  London School of Hygiene and Tropical Medicine

Dr Heidi Larson

Professor of Anthropology, Risk and Decision Science

London School of Hygiene and Tropical Medicine

?

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School of Medicine

Prof Stanley Plotkin

Emeritus Professor

University of Pennsylvania School of Medicine

Dr Peter Hotez, Dean of National School of Tropical Medicine, Baylor College of Medicine

Dr Peter Hotez

Dean of National School of Tropical Medicine

Baylor College of Medicine

?
?

 Dr Paul Offit, Director of the Vaccine Education Centre, The Children’s Hospital of Philadelphia

Dr Paul Offit

Director of the Vaccine Education Centre

The Children’s Hospital of Philadelphia

Dr Roy Baynes, Senior Vice President Global Clinical Development and Chief Medical Officer, Merck

Dr Roy Baynes

Senior Vice President Global Clinical Development and Chief Medical Officer

Merck

?

Alessandro Sette, Center Head, Division Head, and Professor Center for Infectious Disease, La Jolla Institute

Dr Alessandro Sette

Center Head, Division Head?for Infectious Disease

La Jolla Institute

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

Dr Annaliesa Anderson

Vice President and CSO Bacterial Vaccines

Pfizer

?

Dr Walter Straus, Executive Director and Head, Scientific Affairs/ Vaccines, Merck

Dr Walter Straus

Executive Director and Head, Scientific Affairs/ Vaccines

Merck

 Dr George Siber, Exec Director, CSO of ClearPath Vaccines & Chair of Scientific Advisory Board, Genocea Biosciences Inc

Dr George Siber

Exec Director, CSO of ClearPath Vaccines & Chair of Scientific Advisory Board

Genocea Biosciences Inc

Mark Davis, the Burt and Marion Avery Family Professor, Microbiology & Immunology, Stanford University

Prof Mark Davis

Professor, Microbiology & Immunology

Stanford University

Dr Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK

Dr Leonard Friedland

VP, Scientific Affairs and Public Health Vaccines, North America

GSK

?

Dr Jerald Sadoff, Senior Advisor, Janssen Infectious Diseases and Vaccines

Dr Jerald Sadoff

Senior Advisor

Janssen Infectious Diseases and Vaccines

Dr Cyril Gay, Senior National Program Leader, Office of National Programs  USDA

Dr Cyril Gay

Senior National Program Leader, Office of National Programs

USDA

?

DR BERNARD VALLAT                Former Director General                World Organization For                Animal Health Oie

Dr Bernard Vallat

Former Director General

World Organization For Animal Health Oie

Jerome Kim

Dr Jerome Kim

Director General

International Vaccine Institute (IVI)

Ofer Levy

Ofer Levy

Associate Professor of Pediatrics

Harvard Medical School

Gregory Glenn

Dr Gregory M. Glenn

MD, President
Research and Development

Novavax

Dr Ralf Clemens, SVP at GRID Rio, Advisor, Bill & Melinda Gates Foundation

Dr Ralf Clemens

SVP at GRID Rio, Advisor

Bill & Melinda Gates Foundation

Katherine Edwards

Professor of Pediatrics, sarah H Sell & Cornelius Vanderbilt Chair?and Scientific Director?

Vanderbilt Vaccine Research Program

DISCOUNTED TICKETS AVAILABLE!

BOOK BY AUG 30 & SAVE UP TO $1600

OFFER EXPIRES IN

同乐城TLC官网 www.zhaoxuefen.com

Days

Hours

Minutes

Seconds
?
?

What You Missed In 2019

?

WORLD VACCINE CONGRESS WASHINGTON FEATURES
10 CO-CONFERENCES

?

?

World Vaccine Congress - Bioprocess & Manufacturing
World Vaccine Congress - Cancer & Immonotherapy
World Vaccine Congress - Clinical Development
World Vaccine Congress - Emerging Diseases
World Vaccine Congress - Immune Profiling
World Vaccine Congress - Influenza & Respiratory
World Vaccine Congress - Partnerships
World Vaccine Congress - Veterinary

?

World Vaccine Congress Supply & Logistics

World vaccine COngress Vaccine Safety

?

?
?

New vaccine technology is changing the whole industry

?

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.
?

By bringing ten events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just four days out of the office to meet over 1,500+ potential customers who need to find solutions to their challenges.
Build four days of totally tailored content and attendees.

?

DOWNLOAD 2020 BROCHURE

What some of our attendees have to say

?


“The totality of the experience was outstanding!”


Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

“Best vaccine conference in the world.”


CEO, Benchmark Research

“High quality presenters, mix of academia and industry, great talks, original data presented, well thought out symposia, focus on vaccines.”


VP and Director, Global Pneumococcal, Pfizer

?

“Excellent networking and news updates.”


Scientific Advisory Board member, Enesi Pharma Limited

"Probably the strongest conference in the vaccine sector"


Chief Executive Officer, Vaxart, United States

"This is currently the best vaccine meeting in the world, as it combines basic science, clinical product development and regulatory affairs issues with incredible networking."


Co Founder, President & CSO, Epito Genesis Inc

?

"Quality of the professionalism and administration of the conference by the organizers was very good. The talks and presentations were very good. The networking we achieved was very good."


VP Strategic Sales and Services, Meso Scale Diagnostics

Q2 Solutions

"Extremely well organized. Good mix of time for f2f meeting, work streams and keynote speakers. High quality of talks and exhibits."


Chief Scientific Officer, Q2 Solutions


"Great opportunity to Network, Learn of new developments and trends of the industry and obtain Insights to the startegies companies are using to grow their business"


Director, GSK, United States

?

?

?

JOIN US IN DOWNTOWN DC DURING

CHERRY BLOSSOM SEASON!

?

REGISTER NOW

Stay connected

Facebook

Twitter

You Tube

Flickr

?